(Q46555880)

23 December 2017

title

Surgically staged high-risk endometrial cancer: randomized study of adjuvant radiotherapy alone vs. sequential chemo-radiotherapy (English)

1 reference

23 December 2017

0 references

1 reference

Tiina Luukkaala

9

0 references

Tuula Salmi

5

object named as

Tuula Salmi

1 reference

23 December 2017

author name string

Tapio Kuoppala

1

1 reference

23 December 2017

Johanna Mäenpää

2

1 reference

23 December 2017

Eija Tomas

3

1 reference

23 December 2017

Ulla Puistola

4

1 reference

23 December 2017

Seija Grenman

6

1 reference

23 December 2017

Pentti Lehtovirta

7

1 reference

23 December 2017

Matti Fors

8

1 reference

23 December 2017

Pirkko Sipilä

10

1 reference

23 December 2017

language of work or name

English

0 references

publication date

4 June 2008

1 reference

23 December 2017

published in

Gynecologic Oncology

1 reference

23 December 2017

volume

110

1 reference

23 December 2017

issue

2

1 reference

23 December 2017

page(s)

190-195

1 reference

23 December 2017

Features associated with survival and disease-free survival in early endometrial cancer

cites work

1 reference

https://api.crossref.org/works/10.1016%2FJ.YGYNO.2008.03.020

Evaluation of unfavorable histologic subtypes in endometrial adenocarcinoma

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.YGYNO.2008.03.020

Postoperative radiotherapy for endometrial carcinoma. Stage I. Wide variation in referral patterns but no effect on long-term survival in a retrospective study in the southeast Netherlands

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.YGYNO.2008.03.020

Adjuvant radiotherapy following properly staged endometrial cancer: what role?

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.YGYNO.2008.03.020

GOG-99: ending the controversy regarding pelvic radiotherapy for endometrial carcinoma?

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.YGYNO.2008.03.020

Surgery and postoperative radiotherapy versus surgery alone for patients with stage-1 endometrial carcinoma: multicentre randomised trial. PORTEC Study Group. Post Operative Radiation Therapy in Endometrial Carcinoma

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.YGYNO.2008.03.020

Stage I corpus cancer: is teletherapy necessary?

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.YGYNO.2008.03.020

Enteric morbidity of postoperative pelvic external beam and brachytherapy for uterine cancer

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.YGYNO.2008.03.020

Prospective treatment of advanced or recurrent endometrial carcinoma with cisplatin, doxorubicin, and cyclophosphamide

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.YGYNO.2008.03.020

Adjuvant chemotherapy for high-risk endometrial cancer

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.YGYNO.2008.03.020

A phase I study of weekly cisplatin and whole abdominal radiation for the treatment of stage III and IV endometrial carcinoma: a Gynecologic Oncology Group pilot study.

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.YGYNO.2008.03.020

Paclitaxel and carboplatin, alone or with irradiation, in advanced or recurrent endometrial cancer: a phase II study

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.YGYNO.2008.03.020

Paclitaxel and Cisplatin in Advanced or Recurrent Carcinoma of the Endometrium: Long-Term Results of a Phase II Multicenter Study

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.YGYNO.2008.03.020

Feasibility study of concurrent weekly cisplatin and whole abdominopelvic irradiation followed by doxorubicin/cisplatin chemotherapy for advanced stage endometrial carcinoma: a Gynecologic Oncology Group trial

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.YGYNO.2008.03.020

Combined treatment with chemotherapy and radiotherapy in high-risk FIGO stage III-IV endometrial cancer patients

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.YGYNO.2008.03.020

A pilot trial of TAC (paclitaxel, doxorubicin, and carboplatin) chemotherapy with filgastrim (r-metHuG-CSF) support followed by radiotherapy in patients with "high-risk" endometrial cancer

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.YGYNO.2008.03.020

Treatment of recurrent and metastatic endometrial cancer with cisplatin, doxorubicin, cyclophosphamide, and megestrol acetate

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.YGYNO.2008.03.020

Combination chemotherapy for advanced endometrial cancer. An evaluation of three regimens

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.YGYNO.2008.03.020

Adjuvant chemotherapy with cisplatin, doxorubicin, and cyclophosphamide (PAC) for early-stage high-risk endometrial cancer: a preliminary analysis

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.YGYNO.2008.03.020

Postoperative adjuvant cisplatin, doxorubicin, and cyclophosphamide (PAC) chemotherapy in women with high-risk endometrial carcinoma

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.YGYNO.2008.03.020

Persistent chemosensitivity to platinum and/or paclitaxel in metastatic endometrial cancer

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.YGYNO.2008.03.020

Endometrial adenocarcinoma: a primer for the generalist

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.YGYNO.2008.03.020

The Role of Adjuvant Radiotherapy in Carcinoma of the Endometrium—Results in 550 Patients with Pathologic Stage I Disease

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.YGYNO.2008.03.020

A phase III trial of surgery with or without adjunctive external pelvic radiation therapy in intermediate risk endometrial adenocarcinoma: a Gynecologic Oncology Group study

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.YGYNO.2008.03.020

Concomitant radiotherapy and paclitaxel for high-risk endometrial cancer: first feasibility study

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.YGYNO.2008.03.020

Doxorubicin as an adjuvant following surgery and radiation therapy in patients with high-risk endometrial carcinoma, stage I and occult stage II: a Gynecologic Oncology Group Study

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.YGYNO.2008.03.020

Concomitant cisplatin and extended field radiation therapy in patients with cervical and endometrial cancer

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.YGYNO.2008.03.020

10.1016/J.YGYNO.2008.03.020

7 January 2021

Identifiers

DOI

1 reference

23 December 2017

PubMed ID

18534669

1 reference

23 December 2017